Skip to main content
. Author manuscript; available in PMC: 2019 Aug 2.
Published in final edited form as: Cytotherapy. 2017 May 11;19(7):867–880. doi: 10.1016/j.jcyt.2017.04.001

Figure 6.

Figure 6.

T-cell degranulation in the presence of APCs. T cells expressing (A) no CAR molecule, (B) GD2-targeted CAR or (C) CD19-targeted CAR were combined with CD19+ target ALL cell line Nalm-6. Degranulation was measured by quantification of CD107a surface expression.